Ahn Joong Kyong
Divison of Rheumatology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Rheum Dis. 2023 Apr 1;30(2):88-98. doi: 10.4078/jrd.2022.0001. Epub 2023 Mar 17.
Gout is the most common form of inflammatory arthritis that affects mainly middle-aged men, and there is clear evidence of an association between hyperuricemia and the risk for gout. Increasing prevalence of gout and hyperuricemia has been reported in many countries. The prevalence of gout and hyperuricemia are constantly increasing in Korea with the patients at risk for developing a variety of comorbidities. Although there have been studies on the association between gout or serum uric acid level and several neurodegenerative diseases, cancer, and cardiovascular mortality, the causal relationship between gout and these comorbidities are still unclear. The associations of substantial economic burden with hyperuricemia, gout attack, and suboptimal treatment are well known. Gout is a disease that requires lifelong management including lifestyle modification. However, gout is poorly managed worldwide although effective urate-lowering drugs exist. In this review, we addressed epidemiological studies and treatment-related problems in the Korean population with gout or hyperuricemia to obtain the best clinical outcomes and reduce their medical burden.
痛风是最常见的炎性关节炎形式,主要影响中年男性,并且有明确证据表明高尿酸血症与痛风风险之间存在关联。许多国家都报告了痛风和高尿酸血症患病率的上升。在韩国,痛风和高尿酸血症的患病率也在不断增加,患者有发生多种合并症的风险。尽管已有关于痛风或血清尿酸水平与几种神经退行性疾病、癌症及心血管疾病死亡率之间关联的研究,但痛风与这些合并症之间的因果关系仍不明确。高尿酸血症、痛风发作及治疗不充分所带来的巨大经济负担已为人熟知。痛风是一种需要终身管理(包括生活方式改变)的疾病。然而,尽管有有效的降尿酸药物,但痛风在全球范围内的管理情况都很差。在本综述中,我们探讨了韩国痛风或高尿酸血症患者的流行病学研究及治疗相关问题,以获得最佳临床结果并减轻他们的医疗负担。